Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Pharma Industry / Biotech Industry News

Six Universities Aim To Expand Drug Access In Developing Countries

Main Category: Pharma Industry / Biotech Industry
Also Included In: HIV / AIDS;  Aid / Disasters
Article Date: 11 Nov 2009 - 5:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:2 stars

2 (1 votes)

Article Opinions: 0 posts

Six universities have agreed to an effort to "encourage companies to give poor countries better access to drugs and medical products stemming from discoveries made on their campuses," Bloomberg reports (Lauerman, 11/9).

For the effort - Boston University, Brown, Harvard, Oregon Health & Science University, the University of Pennsylvania and Yale - issued a statement (.pdf) on Monday that "describes a number of strategies that would facilitate generic production or below-market pricing," according to a joint press release (11/9).

The principles outlined "will guide how drugs developed by scientists at the schools are licensed to companies, said Kevin Casey, a spokesman for Harvard." According to Bloomberg, "The statement commits the schools to make 'vigorous efforts' to promote global access to drugs through licensing strategies. The six said they will work to include provisions that call for lower prices for drugs to treat AIDS and other diseases that afflict poor countries."

Maryanne Fenerjian, the director of Harvard's technology-transfer policy, said though the schools' aim is to create guidelines that encourage drug access in developing countries, they do not want to dissuade companies from collaborating with university scientists. "The schools will also use strategies such as decreasing royalty rates to persuade companies to charge less or allow low-cost generic production of new drugs for poor patients, she said."

The article also examines efforts by students campaigning for schools to help expand access to drugs and includes comments and concerns about the universities' initiative from the head of Alnylam Pharmaceuticals (11/9).

This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.

© Henry J. Kaiser Family Foundation. All rights reserved.






Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
Criticism Of Popular Oral Contraceptive Yaz Could Harm Product's Appeal, New York Times Reports
29 Sep 2009
The popular oral contraceptives Yaz and Yasmin have been tainted recently by safety concerns raised by researchers, health advocates and lawyers for plaintiffs who have filed lawsuits against manufacturer Bayer Healthcare, the New York Times reports...


How to Build a Better Relationship with Your Doctor
How to Build a Better Relationship with Your Doctor

With appointments lasting 15 minutes or less, it can be hard to communicate with your doctor. But there are some tips on how to get the most out of your visit.

more videos are available in our health videos section.